Skip to main navigation
Skip to search
Skip to main content
Sort by:
Medicine and Dentistry
Programmed Cell Death
100%
Myeloid Leukemia
100%
Tumor Necrosis Factor
100%
Leukemia Cell
100%
Arsenic Trioxide
100%
Cytotoxicity
16%
Interleukin 4
16%
Morphology
16%
Growth Inhibition
16%
Reverse Transcription Polymerase Chain Reaction
16%
Acute Myeloid Leukemia
16%
Northern Blotting
16%
Tumor Necrosis Factor Antibody
16%
Acute Promyelocytic Leukemia
16%
Tumor Necrosis Factor Receptor
16%
Keyphrases
Tumor Necrosis Factor-α
100%
Myeloid Leukemia Cells
100%
Apoptotic Cell Death
100%
Arsenic Trioxide
100%
Growth Inhibition
18%
Cytotoxicity
9%
Dose Effect
9%
Quantitative PCR
9%
Induced Apoptosis
9%
TNF Receptor 1 (TNFR1)
9%
Myeloid Leukemia
9%
Northern Blot Analysis
9%
Interleukin-4 (IL-4)
9%
Subclone
9%
Leukemia Cells
9%
Morphological Differentiation
9%
Acute Promyelocytic Leukemia
9%
Apoptotic nuclei
9%
IL-4Rα
9%
Anti-tumor Necrosis Factor Antibody
9%
Acute Myeloid Leukemia Cells
9%
Autocrine Action
9%
Anti-tumor Necrosis Factor (anti-TNF)
9%
Immunology and Microbiology
Myeloid
100%
Tumor Necrosis Factor
100%
Programmed Cell Death
100%
Leukemia Cell
100%
Reverse Transcription Polymerase Chain Reaction
16%
Cytotoxicity
16%
Morphology
16%
Tumor Necrosis Factor Receptor
16%
Northern Blotting
16%
Interleukin 4
16%
Growth Inhibition
16%
Tumor Necrosis Factor Antibody
16%
Pharmacology, Toxicology and Pharmaceutical Science
Tumor Necrosis Factor
100%
Myeloid Leukemia
100%
Arsenous Acid
100%
Arsenite
100%
Cytotoxicity
16%
Leukemia
16%
Interleukin 4
16%
Promyelocytic Leukemia
16%
Acute Myeloid Leukemia
16%
Tumor Necrosis Factor Receptor
16%
Tumor Necrosis Factor Antibody
16%
Neuroscience
Programmed Cell Death
100%
Necrosis
100%
Myeloid
100%
Arsenic Trioxide
100%
Reverse Transcription Polymerase Chain Reaction
16%
Northern Blot
16%
Cytotoxicity
16%
Interleukin 4
16%
Tumor Necrosis Factor Receptor
16%
Tumor Necrosis Factor Antibody
16%
Nucleus
16%